GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (STU:1RC) » Definitions » PS Ratio

Creo Medical Group (STU:1RC) PS Ratio : 3.29 (As of May. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Creo Medical Group's share price is €0.388. Creo Medical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.12. Hence, Creo Medical Group's PS Ratio for today is 3.29.

The historical rank and industry rank for Creo Medical Group's PS Ratio or its related term are showing as below:

STU:1RC' s PS Ratio Range Over the Past 10 Years
Min: 1.27   Med: 4.47   Max: 37.24
Current: 3.49

During the past 9 years, Creo Medical Group's highest PS Ratio was 37.24. The lowest was 1.27. And the median was 4.47.

STU:1RC's PS Ratio is ranked worse than
52.9% of 809 companies
in the Medical Devices & Instruments industry
Industry Median: 3.29 vs STU:1RC: 3.49

Creo Medical Group's Revenue per Sharefor the six months ended in Dec. 2023 was €0.05. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.12.

Warning Sign:

Creo Medical Group PLC revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Creo Medical Group was -32.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 19.10% per year.

During the past 9 years, Creo Medical Group's highest 3-Year average Revenue per Share Growth Rate was 19.10% per year. The lowest was 19.10% per year. And the median was 19.10% per year.

Back to Basics: PS Ratio


Creo Medical Group PS Ratio Historical Data

The historical data trend for Creo Medical Group's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group PS Ratio Chart

Creo Medical Group Annual Data
Trend Feb14 Feb15 Feb16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only - 32.25 9.72 1.68 4.69

Creo Medical Group Semi-Annual Data
Feb14 Feb15 Feb16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.72 - 1.68 - 4.69

Competitive Comparison of Creo Medical Group's PS Ratio

For the Medical Devices subindustry, Creo Medical Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creo Medical Group's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's PS Ratio distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's PS Ratio falls into.



Creo Medical Group PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Creo Medical Group's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.388/0.118
=3.29

Creo Medical Group's Share Price of today is €0.388.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Creo Medical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.12.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Creo Medical Group  (STU:1RC) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Creo Medical Group PS Ratio Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Creo Medical Group (STU:1RC) Business Description

Traded in Other Exchanges
Address
Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (STU:1RC) Headlines

No Headlines